Article Details
Retrieved on: 2024-04-26 21:23:37
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article analyzes high-risk, high-reward microcap stocks, focusing on five companies under $300 million in market cap. OrganiGram, a medical cannabis producer, is highlighted among others, linking the financial markets with investment strategies in the volatile sector of cannabis.
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here